ArticleJournal of affective disorders reports2025
Sex differences in inflammatory markers in bipolar disorder.
Article in Journal of affective disorders reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Chronic peripheral and brain inflammatory processes contribute to mood disorders. Elevated inflammation may serve as a biomarker for bipolar disorder (BD). Studies have noted sex differences in inflammatory marker levels in the general population, primarily focusing on the effects of surgeries or infections. We explored differences between men and women in serum levels of four inflammatory markers - IL-6, TNF-α, CCL-11, and CRP - among individuals with BD and healthy comparison (HC) participants and compared sex differences between groups. Methods: Data from 156 participants (HC: 49 women, 45 men; BD: 38 women, 24 men) were averaged over three baseline visits of a longitudinal study on inflammation and cognitive aging in BD. Blood samples were collected every week during a two-week period and assessed for biomarker levels using electrochemiluminescence assays. General linear models were applied to examine the main effects of sex, diagnostic group, and sex x diagnostic group for IL-6, TNF-α, CCL-11, and CRP, with smoking, BMI, and age included as covariates. Results: Participants with BD showed higher levels of IL-6 than HC. Sex, diagnostic group, and their interaction showed effects in TNF-α, with higher levels in men with BD and lower levels in HC women. CCL-11 was higher in men than women. CRP levels were higher in BD men than HC men. Conclusions: Men had higher TNF-α serum levels than women; this difference was more pronounced in BD than HC. CRP was elevated in BD compared to HC men. Future anti-inflammatory treatments should consider possible sex differences in BD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.